Literature DB >> 29910196

Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath.

Theodore R Mellors1, Mavra Nasir, Flavio A Franchina, Agnieszka Smolinska, Lionel Blanchet, JoAnne L Flynn, Jaime Tomko, Melanie O'Malley, Charles A Scanga, Philana Ling Lin, Jeff Wagner, Jane E Hill.   

Abstract

In this pilot study, volatile molecules produced by cultures of Mycobacterium tuberculosis were evaluated to determine whether they could be used to discriminate between uninfected and M. tuberculosis-infected macaques. Thirty seven of the culture biomarkers were detectable in macaque breath and were shown to discriminate between uninfected and infected animals with an area under the curve (AUC) of 87%. An AUC of 98% was achieved when using the top 38 discriminatory molecules detectable in breath. We report two newly discovered volatile biomarkers, not previously associated with M. tuberculosis, that were selected in both our in vitro and in vivo discriminatory biomarker suites: 4-(1,1-dimethylpropyl)phenol and 4-ethyl-2,2,6,6-tetramethylheptane. Additionally, we report the detection of heptanal, a previously identified M. tuberculosis breath biomarker in humans, as an in vitro culture biomarker that was detected in every macaque breath sample analyzed, though not part of the in vivo discriminatory suite. This pilot study suggests that molecules from the headspace of M. tuberculosis culture show potential to translate as breath biomarkers for macaques infected with the same strain.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29910196     DOI: 10.1088/1752-7163/aacd18

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   4.538


  8 in total

1.  Determination of tuberculosis-related volatile organic biomarker methyl nicotinate in vapor using fluorescent assay based on quantum dots and cobalt-containing porphyrin nanosheets.

Authors:  Qidi He; Shuangshuang Cai; Jinghao Wu; Ou Hu; Lushan Liang; Zuanguang Chen
Journal:  Mikrochim Acta       Date:  2022-02-16       Impact factor: 5.833

Review 2.  Application of Volatilome Analysis to the Diagnosis of Mycobacteria Infection in Livestock.

Authors:  Pablo Rodríguez-Hernández; Vicente Rodríguez-Estévez; Lourdes Arce; Jaime Gómez-Laguna
Journal:  Front Vet Sci       Date:  2021-05-24

Review 3.  Breath-Based Diagnosis of Infectious Diseases: A Review of the Current Landscape.

Authors:  Chiranjit Ghosh; Armando Leon; Seena Koshy; Obadah Aloum; Yazan Al-Jabawi; Nour Ismail; Zoe Freeman Weiss; Sophia Koo
Journal:  Clin Lab Med       Date:  2021-06       Impact factor: 2.172

Review 4.  Breath Metabolites to Diagnose Infection.

Authors:  Amalia Z Berna; Audrey R Odom John
Journal:  Clin Chem       Date:  2021-12-30       Impact factor: 12.167

5.  Volatile organic compound profiling to explore primary graft dysfunction after lung transplantation.

Authors:  Pierre-Hugues Stefanuto; Rosalba Romano; Christiaan A Rees; Mavra Nasir; Louit Thakuria; Andre Simon; Anna K Reed; Nandor Marczin; Jane E Hill
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

6.  A deep learning approach for detecting liver cirrhosis from volatolomic analysis of exhaled breath.

Authors:  Mikolaj Wieczorek; Alexander Weston; Matthew Ledenko; Jonathan Nelson Thomas; Rickey Carter; Tushar Patel
Journal:  Front Med (Lausanne)       Date:  2022-09-29

7.  Exhaled human breath analysis in active pulmonary tuberculosis diagnostics by comprehensive gas chromatography-mass spectrometry and chemometric techniques.

Authors:  Marco Beccaria; Carly Bobak; Boitumelo Maitshotlo; Theodore R Mellors; Giorgia Purcaro; Flavio A Franchina; Christiaan A Rees; Mavra Nasir; Wendy S Stevens; Lesley E Scott; Andrew Black; Jane E Hill
Journal:  J Breath Res       Date:  2018-11-05       Impact factor: 3.262

Review 8.  Volatilomes of Bacterial Infections in Humans.

Authors:  Moamen M Elmassry; Birgit Piechulla
Journal:  Front Neurosci       Date:  2020-03-25       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.